Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00319865
Status:
UNKNOWN
Last Update Posted:
2006-04-27
First Post:
2006-04-28
Brief Title:
PAD Combination Therapy Followed by ThalDex for Relapsed or Refractory Multiple Myeloma
Sponsor:
Korean Multiple Myeloma Working Party
Organization:
Korean Multiple Myeloma Working Party
Organization Data
Organization:
Korean Multiple Myeloma Working Party
Class:
OTHER
Study ID:
KMM55
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Korean Multiple Myeloma Working Party
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |